The Fundamentals of Antiseizure Medications: A Through Z
Since bromides were first used in 1857 to treat epilepsy, numerous antiseizure medications (ASM) have been developed. Many of these are available for the treatment of epilepsy and status epilepticus today. With so many ASM available, questions arise as to whether all of these medications are needed and when should they be used. As precision medicine begins to play a larger role in determining targeted treatments for specific types of epilepsy, a complete understanding of various medications is needed. Additionally, access to several of these medications can be limited in the United States and are especially limited globally. All these factors can make proper selection of ASM challenging and difficult for clinicians. This review highlights important aspects of older and newer medications, developments in precision medicine for epilepsy, increasing understanding of effective treatments for status epileptics, and a global perspective on ASM availability.
Authors
- David G. Vossler (ORCID: https://orcid.org/0000-0003-4823-0537)
- Timothy E. Welty (ORCID: https://orcid.org/0000-0001-9588-0714)
- Alica M. Goldman (ORCID: https://orcid.org/0000-0002-5491-5746)
- Kristen Park (ORCID: https://orcid.org/0000-0001-5527-3047)
- Archana A. Patel (ORCID: https://orcid.org/0000-0002-1159-0128)
- Jacquelyn Bainbridge (ORCID: https://orcid.org/0000-0001-5649-1564)
- Jeannine M. Conway
Institutions
- Boston Children's Hospital (US)
- University of Minnesota (US)
- Harvard University (US)
- Baylor College of Medicine (US)
- University of Washington (US)
- UnityPoint Health (US)
- University of Colorado Anschutz Medical Campus (US)
- University of Montana (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Epiliepsy currents/Epilepsy currents
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1177/15357597241281838
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00